|
1
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: Moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marcos-Gragera R, Mallone S, Kiemeney LA,
Vilardell L, Malats N, Allory Y and Sant M; EUROCARE-5 Working
Group, : Urinary tract cancer survival in Europe 1999–2007: Results
of the population-based study EUROCARE-5. Eur J Cancer.
51:2217–2230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mahmoud-Ahmed AS, Suh JH, Kupelian PA,
Klein EA, Peereboom DM, Dreicer R and Barnett GH: Brain metastases
from bladder carcinoma: Presentation, treatment and survival. J
Urol. 167:2419–2422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang BH and Liu LZ: PI3K/PTEN signaling
in angiogenesis and tumorigenesis. Adv Cancer Res. 102:19–65. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keniry M and Parsons R: The role of PTEN
signaling perturbations in cancer and in targeted therapy.
Oncogene. 27:5477–5485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puzio-Kuter AM, Castillo-Martin M, Kinkade
CW, Wang X, Shen TH, Matos T, Shen MM, Cordon-Cardo C and
Abate-Shen C: Inactivation of p53 and Pten promotes invasive
bladder cancer. Genes Dev. 23:675–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: MiR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li XJ, Ren ZJ and Tang JH: MicroRNA-34a: A
potential therapeutic target in human cancer. Cell Death Dis.
5:e13272014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun H, Tian J, Xian W, Xie T and Yang X:
miR-34a inhibits proliferation and invasion of bladder cancer cells
by targeting orphan nuclear receptor HNF4G. Dis Markers.
2015:8792542015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang C, Yao Z, Zhu M, Ma X, Shi T, Li H,
Wang B, Ouyang J and Zhang X: Inhibitory effects of microRNA-34a on
cell migration and invasion of invasive urothelial bladder
carcinoma by targeting Notch1. J Huazhong Univ Sci Technolog Med
Sci. 32:375–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB,
Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL,
Andersen CL, Zieger K, et al: Genomic profiling of microRNAs in
bladder cancer: miR-129 is associated with poor outcome and
promotes cell death in vitro. Cancer Res. 69:4851–4860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasaki H, Yoshiike M, Nozawa S, Usuba W,
Katsuoka Y, Aida K, Kitajima K, Kudo H, Hoshikawa M, Yoshioka Y, et
al: Expression level of urinary MicroRNA-146a-5p is increased in
patients with bladder cancer and decreased in those after
transurethral resection. Clin Genitourin Cancer. 14:e493–e499.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsushita R, Seki N, Chiyomaru T,
Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S,
Itesako T, et al: Tumour-suppressive microRNA-144-5p directly
targets CCNE1/2 as potential prognostic markers in bladder cancer.
Br J Cancer. 113:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Hu B, Hu X, Kim H, Squatrito M,
Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, et al: Tumor
evolution of glioma-intrinsic gene expression subtypes associates
with immunological changes in the microenvironment. Cancer Cell.
33:1522018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balaraman S, Schafer JJ, Tseng AM,
Wertelecki W, Yevtushok L, Zymak-Zakutnya N, Chambers CD and
Miranda RC: Plasma miRNA profiles in pregnant women predict infant
outcomes following prenatal alcohol exposure. PLoS One.
11:e01650812016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suzuki K, Yamada H, Nagura A and Ohashi K:
Association of cigarette smoking with serum microRNA expression
among middle-aged Japanese adults. Fujita Med J. 2:1–5. 2016.
|
|
22
|
Jung HJ, Lee KP, Milholland B, Shin YJ,
Kang JS, Kwon KS and Suh Y: Comprehensive miRNA profiling of
skeletal muscle and serum in induced and normal mouse muscle
atrophy during aging. J Gerontol A Biol Sci Med Sci. 72:1483–1491.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bayraktar R, Ivan C, Bayraktar E,
Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D,
Rodriguez-Aguayo C, Arslan A, et al: Dual suppressive effect of
microRNA-34a on the FOXM1/eEF2-kinase axis regulates
triple-negative breast cancer growth and invasion. Clin Cancer Res.
24:4225–4241. 2018. View Article : Google Scholar : PubMed/NCBI
|
